Intensity Therapeutics, Inc.
INTS
$0.282
-$0.009-3.09%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.16M | 1.21M | 1.24M | 1.42M | 1.51M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.71M | 3.39M | 3.20M | 3.57M | 5.07M |
| Operating Income | -2.71M | -3.39M | -3.20M | -3.57M | -5.07M |
| Income Before Tax | -2.54M | -3.35M | -3.18M | -3.51M | -4.97M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.54M | -3.35M | -3.18M | -3.51M | -4.97M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.54M | -3.35M | -3.18M | -3.51M | -4.97M |
| EBIT | -2.71M | -3.39M | -3.20M | -3.57M | -5.07M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.13 | -0.22 | -0.22 | -0.25 | -0.36 |
| Normalized Basic EPS | -0.08 | -0.14 | -0.14 | -0.16 | -0.23 |
| EPS Diluted | -0.13 | -0.22 | -0.44 | -0.25 | -0.36 |
| Normalized Diluted EPS | -0.08 | -0.14 | -0.14 | -0.16 | -0.23 |
| Average Basic Shares Outstanding | 18.87M | 15.17M | 14.40M | 13.80M | 13.71M |
| Average Diluted Shares Outstanding | 18.87M | 15.17M | 14.40M | 13.80M | 13.71M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |